Table 4 Comparison between patients with documented respiratory coinfection versus patients without regarding LOS and laboratory data
From: Respiratory coinfections in COVID-19 patients evaluated by BioFire Pneumonia Panel
Variable | Documented respiratory coinfection (n=20) | No documented respiratory coinfection (n=20) | P-value |
|---|---|---|---|
LOS† | 10.05±6.06 | 9.95±6.77 | 0.961‡ |
TLC† (x103/μL) | 10.71±5.14 | 8.07±3.26 | 0.05‡ |
Ferritin* (ng/ml) | 992 (266–1730) | 595 (334–1241) | 0.194§ |
CRP* (mg/l) | 56.3 (15.8–183.9) | 54.3 (3.8–122.9) | 0.33§ |
Lymphocytes* (absolute value/μL) | 308 (92–486) | 337 (288–574) | 0.337§ |
Highest D-dimer* (ng/ml) | 313 (690–4985) | 221 (458–3487) | 0.317§ |
ALT* (U/L) | 59 (34–184) | 68 (39–108) | 0.73§ |
AST* U/L | 76 (43–129) | 42 (38–72) | 0.02§ |
Bilirubin* (mg/dl) | 0.6 (0.3–0.9) | 0.5 (0.4–0.8) | 0.98§ |
Platelets †(x103/μL) | 356.8±119.27 | 328.5±102.38 | 0.43‡ |
Urea* (mg/dl) | 66 (51–173) | 63 (40.5–132.5) | 0.41§ |
Creatinine* (mg/dl) | 1.1 (0.8–1.4) | 1 (0.9–1.2) | 0.61§ |
Procalcitonin* (ng/ml) | 0.23 (0.07–1.14) | 0.05 (0.05–0.31) | 0.07§ |